Updates are available Correction dated 2018-12-17
Click to view Correction: https://doi.org/10.1038/s41593-018-0277-z
-
Authors
Dong, Xianjun https://orcid.org/0000-0002-8052-9320
Liao, Zhixiang
Gritsch, David
Hadzhiev, Yavor https://orcid.org/0000-0002-1134-4904
Bai, Yunfei
Locascio, Joseph J.
Guennewig, Boris
Liu, Ganqiang
Blauwendraat, Cornelis
Wang, Tao
Adler, Charles H.
Hedreen, John C.
Faull, Richard L. M.
Frosch, Matthew P.
Nelson, Peter T.
Rizzu, Patrizia
Cooper, Antony A.
Heutink, Peter https://orcid.org/0000-0001-5218-1737
Beach, Thomas G.
Mattick, John S. https://orcid.org/0000-0002-7680-7527
Müller, Ferenc https://orcid.org/0000-0002-0996-774X
Scherzer, Clemens R. https://orcid.org/0000-0002-0567-9193
- License Information
-
More Information
Article History
Received: 11 September 2017
Accepted: 23 July 2018
First Online: 17 September 2018
Change Date: 17 December 2018
Change Type: Correction
Change Details: In the version of this article initially published, the legends for Supplementary Figs. 4–8 and 10–14 contained errors. The Supplementary Figure legends have been corrected in the HTML and PDF versions of the article.
Competing interests
: C.R.S. has collaborated with Pfizer and Sanofi; has consulted for Sanofi; has served as Advisor to the Michael J. Fox Foundation, NIH, and Department of Defense; is on the Scientific Advisory Board of the American Parkinson Disease Association; received funding from the NIH, the US Department of Defense, the Michael J. Fox Foundation, and the American Parkinson Disease Association; and is named as co-inventor on two US patent applications on biomarkers for PD held in part by Brigham & Women’s Hospital. B.G. is the founder of Pacific Analytics PTY LTD, Australia and is a founding member of the International Cerebral Palsy Genetics Consortium, a member of the Australian Genomics Health Alliance, and is on the Scientific Advisory Board of Iggy Get Out!, Australia. T.G.B. provides consultancies to Prothena and GSK; is on the Advisory Board of Vivid Genomics; and has contracted research with Avid Radiopharmaceuticals, Navidea Biopharmaceuticals, and Aprinoia Therapeutics. The other authors declare no competing financial interests.
